Oral Gallium Maltolate for Recurrent Glioblastoma

Part of paid clinical trials in Milwaukee, Wisconsin.

Sponsor
Medical College of Wisconsin
Study ID
NCT07515924
Phase
EARLY_PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Gallium Maltolate — DRUG
    Gallium Maltolate will be administered at a total daily dose of 2500 mg.
  • Surgical Intervention — PROCEDURE
    Patients will be scheduled for surgical intervention (needle biopsy or resection) as deemed necessary by the clinical team after 14 ± 5 days of oral Gallium Maltolate administration.

Study Details

This is a Phase 0 investigational study to assess the central nervous system penetration and tumoral concentration of gallium in patients with recurrent glioblastoma administered with preoperative gallium maltolate.

Key Dates

Start date
Jun 30, 2026
Status verified
Mar 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
8 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Gallium Maltolate
    Gallium Maltolate will be administered on an outpatient basis. Subjects will take it for 14 days prior to surgical intervention.

Primary Outcome Measure

Glioma Tissue Difference [ Time Frame: 3 months ]

Central Contacts

  • Medical College of Wisconsin Cancer Center Clinical Trials Office
    866-680-0505
    [email protected]

Locations (1)

FacilityCityStateZIPSite coordinators
Froedtert & the Medical College of WisconsinMilwaukeeWisconsin53226
Rupen Desai, MD
[email protected]
414-955-0950

Find similar trials in Milwaukee, WI

By condition
Brain cancer
By specialty
OncologyNeuro-oncology
By research site
Froedtert & the Medical College of Wisconsin· Milwaukee, WI

Related Studies